Related Experiment Video
Updated: Aug 11, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Long-term prognosis of pulmonary hypertension in silicosis
Abstract:
Sixty patients with silicosis were examined by right heart catheterization and lung function tests during 1958-1966. In the 12-20 years follow-up the information was received of 57 patients (95%). 38 patients died (66.6%), 26 of them of the sequelae of silicosis. The death rate and the length of survival are related to mean pulmonary artery pressure, pressure gradient across pulmonary vascular bed, pulmonary vascular bed, pulmonary vascular resistance (PVR), arterial oxygen saturation (SaO2), vital capacity (VC) and forced expiratory volume (FEV). 12-year mortality in patients with pulmonary hypertension at rest was 81.3%, in contrast to 40.2% in the other patients. No patient with PVR higher than 2.55 u. survived. No patients with SaO2 lower than 89% survived 10 years. Patients with VC higher than 4000 ml at the initial examination are still living. By the method of discriminating analysis 2 main factors determining the prognosis were identified: pulmonary artery pressure and FEV 1".
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

